| BSN Rank:
7 / 57
(What's this?) |
|
Accomplish Score: 3282
|
|
Popularity Score: 24
|
|
# in My Circle: 0
|
|
# in My Org(s): 4
|
| We'll Post Your CV for Free! |
| |
| |
|
Speaking/Presenting-Abstract/Poster at Mtg: 149 (1937 / 0)
|
- Combined modality targeted therapy of pancreatic cancer with anti-DR5 monoclonal antibody (2009)
- Combined modality targeted therapy of pancreatic cancer with anti-DR5 monoclonal antibody. (2009)
- Anti-DR5 Antibody Therapy for Triple Negative Breast Cancer. (2009)
|
| |
|
Honors and Awards: 4 (40 / 0)
|
-
Member of Editorial Board (1996 - 2009)
-
John Hanephin Award of Research Excellence (2005)
-
Investigator (2000 - 2003)
|
| |
|
Clinical Trial Activity: 0 (0 / 0)
|
|
| |
|
Grant Support: 82 (738 / 0)
|
-
Pre-clinical studies of DR5 mediated therapy of TNBC, (2009)
-
Pectin-based microbeads for targeted delivery of imaging and anti-cancer agents (2009)
-
KiSS1 treatment of pancreatic adenocarcinoma (2009)
|
| |
|
Patents Pending: 0 (0 / 0)
|
|
| |
|
Journal - Editor/Reviewer: 0 (0 / 0)
|
|
| |
|
Peer Reviewed Papers, Books, Chapters: 91 (546 / 0)
|
-
Cancer Gene Therapy (2009)
-
Effect of TRA-8 anti-death receptor 5 antibody in combination with chemotherapy in an ex vivo human ovarian cancer model (2009)
-
Cytosine Deaminase/5-fluorocytosine Molecular Cancer Chemotherapy. (2009)
|
| |
|
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
|
|
| |
|
Membership in Professional Societies: 7 (21 / 0)
|
-
NIH (2009 - 2009)
-
NIH (2009 - 2009)
-
NIH (2009 - 2009)
|
| |
|
White Papers: 0 (0 / 0)
|
|
| |
| Registered on BiotechScienceNews: 0 |
How We Rank
